Pfizer to buy Biohaven for $11.6 billion



Pfizer Inc. announced on Tuesday that it is acquiring Biohaven Pharmaceutical Holding Co. Ltd. in a deal worth $11.6 billion or $148.50 per share in cash. Biohaven common shareholders will also receiv…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento